HB 3344
Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House of Delegates
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill proposes establishing a grant program in West Virginia to fund drug development trials of ibogaine, a substance being investigated for treating opioid use disorder and other neurological or mental health conditions. The program would be administered by the state’s Health Secretary and would involve a public-private partnership. It aims to support the Food and Drug Administration’s (FDA) approval process for ibogaine as a medication, including seeking breakthrough therapy designation and establishing trial sites with appropriate cardiac care.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours